Position in INDV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,173,883
New position
Shares Held
126,100
first reported quarter
Ownership
0.107%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#86
of 337 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NATIXIS holds $26,466,635 across 11 Drug Manufacturers - Specialty & Generic names. INDV ranks #3 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
127,706 | $9,176,953 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
14,571 | $7,895,004 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
126,100 | $5,173,883 | |
| 4 | VTRS |
Viatris Inc
|
69,836 | $1,108,995 | |
| 5 | EOLS |
Evolus, Inc.
|
141,437 | $981,572 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
28,444 | $963,682 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
34,000 | $862,580 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
1,061 | $178,820 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,173,883 | 126,100 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||